India vaccinates 190,000 on first day of campaign
Print Edition
India鈥檚 COVID-19 vaccination drive had a successful start on Saturday with more than 190,000 people receiving their first jabs and no one hospitalized for major side effects.
Authorities have given emergency-use approval for two vaccines 鈥 Oxford/AstraZeneca and the homegrown Covaxin, which has yet to complete its Phase-3 trials 鈥 and plans to immunize some 300 million people in the country of 1.3 billion by July.
Front-line workers such as hospital staff, people over 50 and those deemed to be at high risk due to pre-existing medical conditions are on the shortlist.
鈥淲e have got encouraging and satisfactory feedback results on the first day,鈥 Health Minister Harsh Vardhan said on Saturday.
鈥淭his vaccine will indeed be a 鈥Sanjeevani鈥 (life saver)鈥 in the fight against the coronavirus, he added.
The health ministry said 鈥渘o case of post-vaccination hospitalization鈥 had been reported, although local media said a security guard at the country鈥檚 top-ranked public hospital had developed an allergic reaction shortly after getting his vaccine shot.
A doctors鈥 representative body at the Ram Manohar Lohia Hospital in New Delhi wrote a letter asking for the Oxford/AstraZeneca 鈥淐ovishield鈥 vaccine to be supplied instead of Covaxin to allay any fears.
鈥淭he residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination,鈥 said the letter addressing the hospital鈥檚 medical superintendent.
鈥淲e request you to vaccinate us with Covishield, which has completed all stages of trial before its rollout.鈥
Pathologist Arvind Ahuja said at the hospital on Saturday that he shared some of the concerns.
鈥淚 hope when the data comes out, it is good. Ideally, they should have waited for one month at least as then we would have known better about its efficacy.鈥
Vaccine hesitancy has emerged as a major concern, with a recent survey of 18,000 people across India finding that 69 percent were in no rush to get a shot.
Leading scientists and doctors have called on authorities to release efficacy data about Covaxin to boost confidence about the vaccine.
Covaxin recipients on Saturday had to sign a consent form that stated its 鈥渃linical efficacy ... is yet to be established.鈥
Officials had hoped to inoculate 300,000 people on Saturday but said glitches with an app used to coordinate and monitor the process meant not all potential recipients were alerted.
The drive also hit a bump on the first day due to glitches in an app called Co-Win that is being used to coordinate the campaign.
Co-Win, developed by the government, is supposed to help by alerting health-care workers who are first in line to get shots, and by allowing officials monitor and manage the entire drive.
But a lot of health workers who were to receive the vaccines did not get the message on Saturday, said a senior official with the health department of the western state of Maharashtra.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
